Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HIV Protease anticorps

Reactivité: Human Immunodeficiency Virus (HIV) ELISA, WB Hôte: Souris Monoclonal 1696 unconjugated
N° du produit ABIN94325
  • Antigène
    HIV Protease
    Reactivité
    • 2
    • 1
    Human Immunodeficiency Virus (HIV)
    Hôte
    • 3
    Souris
    Clonalité
    • 3
    Monoclonal
    Conjugué
    • 3
    Inconjugué
    Application
    • 3
    • 3
    • 3
    ELISA, Western Blotting (WB)
    Specificité
    The antibody 1696 recognizes free N-terminus of mature HIV protease (HIV-1 and HIV-2), an enzyme that hydrolyzes polyproteins of HIV viruses into functional proteins. The antibody 1696 does not react with the precursor.
    Réactivité croisée (Details)
    HIV
    Purification
    Purified by protein-A affinity chromatography.
    Pureté
    > 95 % (by SDS-PAGE)
    Immunogène
    Bacterially expressed full-length HIV-1 protease
    Clone
    1696
    Isotype
    IgG1
  • Indications d'application
    Western blotting: Recommended dilution: 0.5 μg/mL.
    Restrictions
    For Research Use only
  • Concentration
    1 mg/mL
    Buffer
    Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Do not freeze.
    Stock
    4 °C
    Stockage commentaire
    Store at 2-8°C. Do not freeze.
  • Hallengärd, Haller, Petersson, Boberg, Maltais, Isaguliants, Wahren, Bråve: "Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity." dans: Vaccine, Vol. 29, Issue 4, pp. 839-48, (2011) (PubMed).

    Bartonová, Král, Sieglová, Brynda, Fábry, Horejsí, Kozísek, Sasková, Konvalinka, Sedlácek, Rezácová: "Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies." dans: Antiviral research, Vol. 78, Issue 3, pp. 275-7, (2008) (PubMed).

    OLoughlin, Greene, Matsumura: "Diversification and specialization of HIV protease function during in vitro evolution." dans: Molecular biology and evolution, Vol. 23, Issue 4, pp. 764-72, (2006) (PubMed).

    Lescar, Brynda, Rezacova, Stouracova, Riottot, Chitarra, Fabry, Horejsi, Sedlacek, Bentley: "Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody." dans: Protein science : a publication of the Protein Society, Vol. 8, Issue 12, pp. 2686-96, (2000) (PubMed).

  • Antigène
    HIV Protease
    Classe de substances
    Viral Protein
    Sujet
    The HIV protease (PR) hydrolyzes polyproteins of HIV virus into functional protein products that are essential for its assembly and subsequent activity. This maturation process occurs as the virion buds from the host cell. HIV protease inhibitors are used in the treatment of patients with AIDS and were considered the first breakthrough in over a decade of AIDS research. HIV protease inhibitors can lower the viral load carried by AIDS patents.,HIV-1 PR, HIV-2 PR
Vous êtes ici:
Support technique